Search research articles
Contact Us
Filters
Showing results (181-190 of 238) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2015
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors
Benjamin K Tomlinson, James A Thomson, John S Bomalaski, et al.
JAMA Network Open
|
August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial
Shuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
Clinical Lung Cancer
|
November 24, 2020
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design
Jonathan W Riess, Paul Frankel, David Shackelford, et al.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
European Urology Oncology
|
November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216
Umang Swami, Yeonjung Jo, Arshit Narang, et al.
Investigational New Drugs
|
November 19, 2013
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E Rosenberg, Richard M Bambury, Eliezer M Van Allen, et al.
JCO Precision Oncology
|
September 9, 2020
Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
Ethan S Sokol, Dean Pavlick, Hossein Khiabanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2019
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
Sarina A Piha-Paul, Jasgit C Sachdev, Minal Barve, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
The New England Journal of Medicine
|
October 8, 2004
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 238) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2015
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors
Benjamin K Tomlinson, James A Thomson, John S Bomalaski, et al.
JAMA Network Open
|
August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial
Shuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
Clinical Lung Cancer
|
November 24, 2020
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design
Jonathan W Riess, Paul Frankel, David Shackelford, et al.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
European Urology Oncology
|
November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216
Umang Swami, Yeonjung Jo, Arshit Narang, et al.
Investigational New Drugs
|
November 19, 2013
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E Rosenberg, Richard M Bambury, Eliezer M Van Allen, et al.
JCO Precision Oncology
|
September 9, 2020
Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
Ethan S Sokol, Dean Pavlick, Hossein Khiabanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2019
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
Sarina A Piha-Paul, Jasgit C Sachdev, Minal Barve, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
The New England Journal of Medicine
|
October 8, 2004
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, et al.
Page
of 24